Diclofenac sodium is one of the most widely used NSAIDS and its short half-life of 1-2 h necessitates preparation of a controlled release formulation. Spray drying, a one step process establishes intimate contact of the drug with the polymer and finds increasing applications in the area of controlled release formulations. Eudragit NE 30D is reported to be useful for preparation of controlled release formulations. An attempt has been made to prepare microparticles of diclofenac sodium with Eudragit NE 30D, using spray-drying technology in aqueous system. Aerosil was found to overcome the tackiness caused by Eudragit NE 30D and improved yield and flowability of the product, while talc did not overcome tackiness and did not prove to be suitable excipient. The microparticles were evaluated for percent yield, average particle size and flowability and were compressed into tablets. The tablets were studied for drug assay and dissolution profiles. The tablets containing drug polymer ratio of 1:1.212 were found to release the drug at the rate of 9.3 mg/h over the period of 10 h.
Diclofenac sodium with its low oral bioavailability, short flow rate and feed rate were set to desired value and plasma half life and low dose is an ideal candidate for spray drying of the slurry was carried out and the spray formulation as a controlled release drug delivery system dried product collected in glass cyclone collector. for chronic pain associated with musculoskeletal disorders like arthritis and gout 1 . Spray drying is a single step, cost Spray drying conditions were optimized at drying air effective technique that establishes intimate contact of the temperature 275°, drying airflow rate 6 cfm, feed rate drug with the release retardant and is being used 9 ml/min and atomizing pressure 2 kgf/cm 2 . successfully to prepare controlled release products 2, 3 . Eudragit NE 30D is an acrylic polymer, which has been Spray dried microparticles were assessed for percent reported to be useful in the preparation of controlled yield, particle size and flowability. Particle size was release products 4, 5 . It is available as 30% aqueous measured using a calibrated optical microscope. dispersion and offers advantage of being used in aqueous Flowability was measured in terms of angle of repose of system for spray drying. However it causes tackiness and the spray-dried product. Angle of repose was measured therefore talc and Aerosil were evaluated as excipients to using fixed funnel and free standing cone method 6 . The improve this property.
spray-dried microparticles were compressed into tablets (9.5 mm diameter) on a single stroke-punching machine A table top mini spray dryer (S. M. Scientech, Kolkata) and were evaluated for drug assay at 285 nm. Dissolution fitted with a borosilicate glass chamber, two fluid nozzle, was carried out using validated USP dissolution rate peristaltic pump with variable speed arrangement, air apparatus in pH 7.2 buffer maintaining the temperature at blower with concurrent air flow, sheathed air heater with 37° and stirring speed of 100 rpm. thermostatic control and a glass cyclone collector was used for the study. Diclofenac sodium was mixed with the Compositions and evaluation results of spray-dried polymer and the excipient. Water was added to the microparticles containing Eudragit NE30D and talc have above mixture to get the feed concentration of around been tabulated in Table 1 . All the products showed 30%. The slurry was stirred well and kept on magnetic particle size in the range of 10-15 µm. Products A1 to stirrer through out the spray drying process. Instrument A5, except A2 contain Eudragit NE30D and talc in the related variables like drying air temperature, drying air ratio of 0.303:2. These products showed good flowability but had low yield of around 40%. As the polymer content *For correspondence in the formulations was increased, talc content had to be E-mail: kksingh35@rediffmail.com increased to maintain a minimal ratio of polymer: talc,
Indian Journal of Pharmaceutical Sciences0.303:2. Spray dried product A2 containing higher amount of talc (0.303:2.5) did not show any improvement in flowability or percent yield of the product. These spraydried microparticles were further compressed into tablets and the tablets were evaluated for drug assay and dissolution characteristics ( Table 2 . Spray dried products containing polymer aerosil ratio of 0.303:0.1 (formulation B5) showed good flowability and high percent yield. Aerosil was found to decrease the tackiness of the polymer and overcome the agglomeration thus increasing the flowability and percent yield of the product. Addition of Aerosil also decreased the size of microparticles, which can be attributed to the decreased agglomeration of the product. However, any further increase in the amount of Aerosil (formulation B6) was not found to improve the product characteristics any further.
These spray-dried particles were tabletted and evaluated as earlier. As the polymer concentration was increased drug release rate was found to decrease. Tablets B6 containing drug: polymer ratio of 1:1.212 released the drug at the rate of 9.55 mg/h over the period of 10 h. Lower concentration of Eudragit NE30D (formulation B1 and B2) gave a t 90% of 6.30 and 7.05 h respectively but the drug release did not follow zero order kinetics. As the polymer concentration was increased to drug:polymer ratio of 1:1.06 (formulations B3 and B4) and 1:1.212 (formulations B5 and B6), the t 90% increased to 7.9 and 9.1 h, respectively. Tablets B5 with optimized drug, polymer and Aerosil ratio released the drug at the rate of 9.31 mg/h over the period of 10 h. These formulations were found to follow zero order drug release kinetics as is evident from the coefficient of correlation value of drug release vs. time profiles.
Overlapping dissolution profiles of tablets B3 and B4 containing same amount of polymer but different amount of Aerosil indicates that Aerosil did not have any effect on dissolution profiles ( fig. 1 ). Thus spraying drying was found to be a suitable method for preparing controlled release tablets of diclofenac sodium with precise zero order release while Eudragit NE30D has proved to be a useful polymer for formulating a controlled release product using spray drying technology in an aqueous system.
